October 8, 2021 — HealthLevel, Inc., innovator of Foundations, a business operations analytics platform for healthcare institutions, announced the successful deployment of its comprehensive enterprise analytics solution across the Veterans Health Administration's VISN 8 network in Florida.

October 7, 2021 — An automated system that uses artificial intelligence (AI) can quickly and accurately sift through breast MRIs in women with dense breasts to eliminate those without cancer, freeing up radiologists to focus on more complex cases, according to a study published in 

October 7, 2021 — The Radiological Society of North America (RSNA) announced a slate of programming promoting health care diversity, equity and inclusion to be presented at the Society’s upcoming annual meeting.

October 7, 2021 — NANOBIOTIX, a late-stage clinical biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer, today announced two oral presentations and three poster presentations at the 2021 Annual Meeting of the American Society for Radiation Oncology (ASTRO). The meeting will be held from October 24-27, 2021.

October 7, 2021 — ViewRay, Inc. announced that the company has received acceptance from the FDA on their recent submission for new MRIdian features focused on enhancing on-table adaptive workflow efficiency and expanding clinical utility.

October 6, 2021 — Fujifilm Medical Systems U.S.A., Inc. and Fujifilm Healthcare Americas Corporation (formerly Hitachi Healthcare Americas) today announce that the two companies have merged and are operating under the name FUJIFILM Healthcare Americas Corporation. The new combined organization brings together the strengths of each company’s innovative product portfolios and talented employees to create new value for customers and advance medical care. 

October 6, 2021 — A commentary by Mayo Clinic Cancer Center researchers published in the Journal of Clinical Oncology Practice suggests that advances in breast cancer prevention research have resulted in new and innovative opportunities to modify breast cancer risk and potentially reduce breast cancer incidence and mortality.


October 6, 2021 – A new study published in Radiology: Cardiothoracic Imaging on cardiac imaging trends over a decade reports that the rate of coronary computed tomography angiography (CCTA) exams by radiologists in hospital outpatient departments increased markedly from 2010 to 2019.[1] This suggests a bright future for the technology.


October 5, 2021 — A promising radionuclide treatment may offer new therapeutic options for breast cancer patients, according to research published in The Journal of Nuclear Medicine. The treatment combines radioactive iodine therapy with single-domain antibodies that target the human epidermal growth factor receptor type 2 (

Subscribe Now